» Articles » PMID: 37681566

Age at Menopause and the Risk of Stroke: Observational and Mendelian Randomization Analysis in 204 244 Postmenopausal Women

Abstract

Background Observational studies have shown that women with an early menopause are at higher risk of stroke compared with women with a later menopause. However, associations with stroke subtypes are inconsistent, and the causality is unclear. Methods and Results We analyzed data of the UK Biobank and EPIC-CVD (European Prospective Investigation Into Cancer and Nutrition-Cardiovascular Diseases) study. A total of 204 244 postmenopausal women without a history of stroke at baseline were included (7883 from EPIC-CVD [5292 from the subcohort], 196 361 from the UK Biobank). Pooled mean baseline age was 58.9 years (SD, 5.8), and pooled mean age at menopause was 47.8 years (SD, 6.2). Over a median follow-up of 12.6 years (interquartile range, 11.8-13.3), 6770 women experienced a stroke (5155 ischemic strokes, 1615 hemorrhagic strokes, 976 intracerebral hemorrhages, and 639 subarachnoid hemorrhages). In multivariable adjusted observational Cox regression analyses, the pooled hazard ratios per 5 years younger age at menopause were 1.09 (95% CI, 1.07-1.12) for stroke, 1.09 (95% CI, 1.06-1.13) for ischemic stroke, 1.10 (95% CI, 1.04-1.16) for hemorrhagic stroke, 1.14 (95% CI, 1.08-1.20) for intracerebral hemorrhage, and 1.00 (95% CI, 0.84-1.20) for subarachnoid hemorrhage. When using 2-sample Mendelian randomization analysis, we found no statistically significant association between genetically proxied age at menopause and risk of any type of stroke. Conclusions In our study, earlier age at menopause was related to a higher risk of stroke. We found no statistically significant association between genetically proxied age at menopause and risk of stroke, suggesting no causal relationship.

Citing Articles

Mitochondria: the epigenetic regulators of ovarian aging and longevity.

Mani S, Srivastava V, Shandilya C, Kaushik A, Singh K Front Endocrinol (Lausanne). 2024; 15:1424826.

PMID: 39605943 PMC: 11598335. DOI: 10.3389/fendo.2024.1424826.


Modifiable Risk Factors for Subarachnoid Hemorrhage: Narrative Review With an Emphasis on Common Controversies and Epidemiologic Pitfalls.

Rautalin I, Asikainen A, Korja M Neurology. 2024; 103(11):e210052.

PMID: 39556778 PMC: 11627175. DOI: 10.1212/WNL.0000000000210052.


Age at Natural Menopause and Influencing Factors in Women Attending the Gynecological Outpatient Clinic at a Tertiary Care Hospital.

Yusuf Ali K, Erkok U, Mohamed N, Hilowle N, Elmi H, Haji Mohamud R Int J Womens Health. 2023; 15:1627-1636.

PMID: 37908284 PMC: 10615107. DOI: 10.2147/IJWH.S434123.

References
1.
Woodfield R, Grant I, Sudlow C . Accuracy of Electronic Health Record Data for Identifying Stroke Cases in Large-Scale Epidemiological Studies: A Systematic Review from the UK Biobank Stroke Outcomes Group. PLoS One. 2015; 10(10):e0140533. PMC: 4619732. DOI: 10.1371/journal.pone.0140533. View

2.
Zheng J, Luan J, Sofianopoulou E, Imamura F, Stewart I, Day F . Plasma Vitamin C and Type 2 Diabetes: Genome-Wide Association Study and Mendelian Randomization Analysis in European Populations. Diabetes Care. 2020; 44(1):98-106. PMC: 7783939. DOI: 10.2337/dc20-1328. View

3.
Zhu D, Chung H, Dobson A, Pandeya N, Giles G, Bruinsma F . Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019; 4(11):e553-e564. PMC: 7118366. DOI: 10.1016/S2468-2667(19)30155-0. View

4.
Thompson S . Why sources of heterogeneity in meta-analysis should be investigated. BMJ. 1994; 309(6965):1351-5. PMC: 2541868. DOI: 10.1136/bmj.309.6965.1351. View

5.
Lankester J, Li J, Salfati E, Stefanick M, Katie Chan K, Liu S . Genetic evidence for causal relationships between age at natural menopause and the risk of ageing-associated adverse health outcomes. Int J Epidemiol. 2022; 52(3):806-816. PMC: 10244052. DOI: 10.1093/ije/dyac215. View